Hodgkin Disease
📧 Sign up to get email alerts when something new happens for Hodgkin Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD [NA]
A pediatric clinical trial update examining imaging of chemotherapy-induced lung changes in childhood acute lymphoblastic leukemia and Hodgk…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor [Phase 2]
Phase II trial evaluating safety and efficacy of subcutaneous plerixafor in related donors of peripheral blood stem cells for various hemato…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention [Phase 3]
Phase 3 trial comparing Tacrolimus plus mini-methotrexate versus Tacrolimus plus methotrexate for graft-versus-host disease prevention has c…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, [Phase 3]
Phase 3 trial comparing nivolumab plus brentuximab vedotin vs brentuximab vedotin alone in advanced stage classical Hodgkin lymphoma; trial …
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [Phase 2]
Phase II study evaluating filgrastim (G-CSF) plus ABVD chemotherapy in HIV-associated Hodgkin's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Stem Cell Transplant for Hematological Malignancy [NA]
Clinical trial update on stem cell transplantation for hematologic malignancies; status terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase II trial of lenalidomide for relapsed or refractory Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies [Phase 3]
Phase 3 trial of umbilical cord blood cells expanded with MPCs for transplantation in hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma [Phase 1]
Phase 1 trial update on leukemia/lymphoma patients using LMP-specific T-cells for relapsed EBV-positive lymphoma; results posted for a compl…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) [Phase 2]
Phase 2 clinical trial update on Brentuximab Vedotin in Chinese participants with relapsed/refractory CD30-positive Hodgkin lymphoma or syst…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies [Phase 2]
Phase 2 clinical trial evaluating BL-8040 for mobilizing donor hematopoietic stem cells to enable allogeneic transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies [Phase 1, Phase 2]
A pilot Phase 1/2 study evaluating safety and efficacy of NiCord and UNM CBU in patients with various hematologic malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma [Phase 2]
Phase 2 trial assessing maintenance rituximab combined with mTOR inhibition after high-dose consolidative therapy in various B-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]
Phase 2 clinical trial update evaluating PD and safety of TG-0054 in combination with G-CSF for patients with multiple myeloma and lymphomas…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab in elderly patients with re…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial investigating Yttrium-90-labeled daclizumab with chemotherapy and stem cell transplant in Hodgkin lymphoma has terminated; re…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update on Rituximab for Non-Hodgkin's lymphoma or Hodgkin's disease; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT [NA]
This trial assessed whether rituximab (Rituxan) can prevent EBV-associated lymphoproliferative disorder after T-cell-depleted unrelated or H…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma [Phase 2]
A Phase 2 clinical trial evaluated the efficacy and treatment-related toxicity of a new regimen for lymphoma, including Non-Hodgkin's Lympho…
-
CLINICAL_TRIALS withdrawal · 2015-03-24Clinical Trial Update: This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.
This entry describes an expanded-access, multi-center, single-arm, open-label study of plerixafor for patients with non-Hodgkin's lymphoma, …
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies [Phase 1]
A Phase I trial evaluating vorinostat in combination with niacinamide and etoposide for Hodgkin's disease and non-Hodgkin's lymphoma has com…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]
Phase 2 safety and PK/PD study of TG-0054 in patients with multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease has completed with re…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [NA]
Tamoxifen was studied in a completed clinical trial to prevent breast cancer in survivors of Hodgkin's disease. The study was sponsored by D…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Phase 1]
Phase 1 pharmacokinetics and safety study of azacitidine in cancer patients with and without impaired renal function has completed. Results …